Author

V. D. de Souza

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Beyond strongyloides: rationale for empirical antiparasitic prophylaxis in immunosuppressed patients with rheumatic diseases in endemic areas

Intestinal parasitic infections remain highly prevalent in endemic regions such as Brazil and pose a significant risk to patients with immune-mediated rheumatic diseases (IMRDs) undergoing immunosuppressive therapy. Immunosuppression may alter the natural history of parasitic infections, particularly Strongylo...

V. Cruz, L. D. de Azevedo Valadares, Clarice Moura Mata Machado et al. · Advances in Rheumatology · 0 citations

Open access Aug 2026

Lack of association between rheumatoid factor levels and clinical response to certolizumab pegol in patients with rheumatoid arthritis: an observational study

Background Patients with rheumatoid arthritis (RA) generally have elevated levels of rheumatoid factor (RF), which binds to the crystallizable fraction (Fc) of monoclonal antibodies, diminishing tumour necrosis factor inhibitor (TNFi) efficacy. We assessed clinical response to PEGylated, Fc-free certolizumab pegol (CZP...

A. Kakehasi, João Gabriel Leão Sperancini Amaral, Jéssica Martins Amaral et al. · Drugs in Context · 0 citations

Open access Jul 2026

Immunogenicity and safety of BNT162b2 vaccine in patients with juvenile immune mediated inflammatory disease.

The BNT162b2 vaccine was safe and immunogenic in adolescents with IMIDs, including those with high immunosuppression and comorbidities, showing similar responses to adults, which support vaccination in this vulnerable population and contribute to evidence-based recommendations.

C. Gadelha, Maria Teresa Terreri, A. Burian et al. · Pediatric Research · 0 citations